Cargando…

Gadofosveset-enhanced magnetic resonance angiography

Gadofosveset (Vasovist(®), Bayer Schering Pharma AG, Berlin/Germany) is the first intravascular contrast agent approved for use with magnetic resonance angiography in the European Union, Switzerland, Turkey, Canada, and Australia. Gadofosveset reversibly binds to albumin providing extended intravasc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Goyen, Mathias
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464762/ https://www.ncbi.nlm.nih.gov/pubmed/18629367

Ejemplares similares

Gadofosveset trisodium in coronary magnetic resonance angiography at 3 Tesla
por: Raman, Fabio S, et al.
Publicado: (2014)

Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging
por: Schreinemacher, Marc H., et al.
Publicado: (2012)

High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol
por: Shahrouki, Puja, et al.
Publicado: (2021)

Gadofosveset-Trinatrium-Enhanced MR Angiography and MR Venography in the Diagnosis of Venous Thromboembolic Disease: A Single-Center Cohort Study
por: Aschauer, Manuela A., et al.
Publicado: (2022)

Part 1 – Coronary angiography with gadofosveset trisodium: a prospective feasibility study evaluating injection techniques for steady-state imaging
por: Ahlman, Mark A., et al.
Publicado: (2015)

Part 2 – Coronary angiography with gadofosveset trisodium: a prospective intra-subject comparison for dose optimization for 100 % efficiency imaging
por: Ahlman, Mark A., et al.
Publicado: (2016)

Overcoming the Low Relaxivity of Gadofosveset at High Field with Spin Locking
por: Richardson, O C, et al.
Publicado: (2012)

Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities
por: Arnoldussen, Carsten W. K. P., et al.
Publicado: (2017)

MRI with gadofosveset: A potential marker for permeability in myocardial infarction
por: Lavin, Begoña, et al.
Publicado: (2018)

Optimization of gadofosveset intravenous injection scheme for coronary MRA: the pharmacokinetics approach
por: Ahlman, Mark A, et al.
Publicado: (2014)

CMR Assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset
por: Pedersen, Steen F, et al.
Publicado: (2011)

Imaging of aortic coarctation using Gd-DTPA and Gadofosveset: a comparative study
por: Greil, Gerald F, et al.
Publicado: (2009)

Gadolinium-enhanced magnetic resonance angiography in brain death
por: Luchtmann, M., et al.
Publicado: (2014)

Gadofosveset-Based Biomarker of Tissue Albumin Concentration: Technical Validation in Vitro and Feasibility in Vivo
por: Richardson, Owen C, et al.
Publicado: (2015)

In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform
por: Spanakis, Marios, et al.
Publicado: (2014)

Assessment of the kidneys: magnetic resonance angiography, perfusion and diffusion
por: Attenberger, Ulrike I, et al.
Publicado: (2011)

Magnetic resonance angiography: current status and future directions
por: Hartung, Michael P, et al.
Publicado: (2011)

Quiescent-Interval Single-Shot Magnetic Resonance Angiography
por: Saini, Aman, et al.
Publicado: (2018)

The Optimization of Scan Timing for Contrast-Enhanced Magnetic Resonance Angiography
por: Lee, Jongmin J., et al.
Publicado: (2000)

Unenhanced magnetic resonance angiography as an accurate alternative in the preoperative assessment of potential living kidney donors with contraindications to computed tomography angiography and to contrast-enhanced magnetic resonance angiography
por: Velloni, Fernanda Garozzo, et al.
Publicado: (2020)

Image Quality and Stenosis Assessment of Non-Contrast-Enhanced 3-T Magnetic Resonance Angiography in Patients with Peripheral Artery Disease Compared with Contrast-Enhanced Magnetic Resonance Angiography and Digital Subtraction Angiography
por: Liu, Jiayi, et al.
Publicado: (2016)

Visualization of Chronic Myocardial Infarction Using the Intravascular Contrast Agent MS-325 (Gadofosveset) in Patients
por: Thouet, Thomas, et al.
Publicado: (2012)

A Comparison between Gadofosveset Trisodium and Gadobenate Dimeglumine for Steady State MRA of the Thoracic Vasculature
por: Camren, G. Paul, et al.
Publicado: (2014)

Magnetic Resonance Angiography in the Diagnosis of Cerebral Arteriovenous Malformation and Dural Arteriovenous Fistulas: Comparison of Time-Resolved Magnetic Resonance Angiography and Three Dimensional Time-of-Flight Magnetic Resonance Angiography
por: Cheng, Yu-Ching, et al.
Publicado: (2016)

Blood Pool Contrast-enhanced Magnetic Resonance Angiography with Correlation to Digital Subtraction Angiography: A Pictorial Review
por: Knuttinen, Martha-Grace, et al.
Publicado: (2014)

Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients
por: Stoumpos, Sokratis, et al.
Publicado: (2017)

Bolus characteristics based on Magnetic Resonance Angiography
por: Cai, Zhijun, et al.
Publicado: (2006)

Fluorine-19 Magnetic Resonance Angiography of the Mouse
por: van Heeswijk, Ruud B., et al.
Publicado: (2012)

Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium
por: Nacif, Marcelo Souto, et al.
Publicado: (2018)

Non-contrast coronary magnetic resonance angiography: current frontiers and future horizons
por: Kato, Yoko, et al.
Publicado: (2020)

Ferumoxytol-Enhanced Coronary Magnetic Resonance Angiography Compared to Invasive Coronary Angiography for Detection of Epicardial Coronary Artery Disease
por: Miller, Timothy, et al.
Publicado: (2020)

Improved high-resolution pediatric vascular cardiovascular magnetic resonance with gadofosveset-enhanced 3D respiratory navigated, inversion recovery prepared gradient echo readout imaging compared to 3D balanced steady-state free precession readout imaging
por: Tandon, Animesh, et al.
Publicado: (2016)

Gadofosveset-enhanced MRI as simple surrogate parameter for real-time evaluation of the initial tumour vessel infarction by retargeted tissue factor tTF-NGR
por: Höink, Anna, et al.
Publicado: (2019)

Contrast enhanced magnetic resonance angiography in children: initial experience at 3.0 Tesla
por: Khan, SN, et al.
Publicado: (2013)

Impact of source data on the interpretation of contrast-enhanced magnetic resonance angiography of the lower limbs
por: Lewis, Mark, et al.
Publicado: (2014)

Thyroid Nodules Detected by Contrast-Enhanced Magnetic Resonance Angiography: Prevalence and Clinical Significance
por: Lim, Hyun Kyung, et al.
Publicado: (2016)

Feasibility of contrast-enhanced coronary artery magnetic resonance angiography using compressed sensing
por: Hirai, Kuniaki, et al.
Publicado: (2020)

Non-contrast free-breathing 3D cardiovascular magnetic resonance angiography using REACT (relaxation-enhanced angiography without contrast) compared to contrast-enhanced steady-state magnetic resonance angiography in complex pediatric congenital heart disease at 3T
por: Isaak, Alexander, et al.
Publicado: (2022)

Non-Contrast-Enhanced and Contrast-Enhanced Magnetic Resonance Angiography in Living Donor Liver Vascular Anatomy
por: Liao, Chien-Chang, et al.
Publicado: (2022)

Ferumoxytol-Enhanced Cardiac Magnetic Resonance Angiography and 4D Flow: Safety and Utility in Pediatric and Adult Congenital Heart Disease
por: Renella, Pierangelo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_veb2piplqo6ug2reqkoc79g41a